AdaptHealth (AHCO) Panoramica del titolo
AdaptHealth Corp., insieme alle sue consociate, distribuisce apparecchiature mediche a domicilio (HME), forniture mediche e servizi a domicilio e correlati negli Stati Uniti. Maggiori dettagli
| Punteggio fiocco di neve | |
|---|---|
| Valutazione | 6/6 |
| Crescita futura | 3/6 |
| Prestazioni passate | 0/6 |
| Salute finanziaria | 3/6 |
| Dividendi | 0/6 |
Premi
Analisi del rischio
AHCO Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Concorrenti di AdaptHealth Corp.
Storia dei prezzi e prestazioni
| Prezzi storici delle azioni | |
|---|---|
| Prezzo attuale dell'azione | US$5.69 |
| Massimo di 52 settimane | US$13.43 |
| Minimo di 52 settimane | US$5.67 |
| Beta | 1.46 |
| Variazione di 1 mese | -43.04% |
| Variazione a 3 mesi | -49.65% |
| Variazione di 1 anno | -38.08% |
| Variazione a 3 anni | -59.01% |
| Variazione a 5 anni | -77.35% |
| Variazione dall'IPO | -40.73% |
Notizie e aggiornamenti recenti
Articolo di analisi • Aug 07
AdaptHealth Corp. Just Missed Earnings; Here's What Analysts Are Forecasting Now
One of the biggest stories of last week was how AdaptHealth Corp. ( NASDAQ:AHCO ) shares plunged 43% in the week since...
Aggiornamento narrativa • Aug 05
AHCO: Capitation Expansion And Cost Efficiencies Will Drive Future Earnings Profile
Analysts trimmed their fair value estimate for AdaptHealth from $12 to $10, citing higher discount rate assumptions, softer revenue growth expectations, a lower future P/E multiple, and updated views following the divestment of the diabetes business, new capitation agreements, and the recent cyberattack. Analyst Commentary on AdaptHealth Recent Street research on AdaptHealth shows a mix of optimism and caution.Recent updates
Articolo di analisi • Aug 07
AdaptHealth Corp. Just Missed Earnings; Here's What Analysts Are Forecasting Now
One of the biggest stories of last week was how AdaptHealth Corp. ( NASDAQ:AHCO ) shares plunged 43% in the week since...Aggiornamento narrativa • Aug 05
AHCO: Capitation Expansion And Cost Efficiencies Will Drive Future Earnings Profile
Analysts trimmed their fair value estimate for AdaptHealth from $12 to $10, citing higher discount rate assumptions, softer revenue growth expectations, a lower future P/E multiple, and updated views following the divestment of the diabetes business, new capitation agreements, and the recent cyberattack. Analyst Commentary on AdaptHealth Recent Street research on AdaptHealth shows a mix of optimism and caution.Aggiornamento narrativa • Jul 21
AHCO: Business Mix Shift And Cybersecurity Response Will Shape Future Earnings Profile
Analysts have increased their fair value estimate for AdaptHealth to $12.00 from $11.00. This change reflects updated views on growth, margins and potential multiple support following recent price target changes and shifts in the business mix.
Aggiornamento narrativa • Jul 06
AHCO: Cyber Resilience And Execution Will Support Future Cash Flow Repricing
The updated analyst price target for AdaptHealth has been revised from $18 to $16, as analysts factor in the recent cyberattack while still reflecting modestly adjusted expectations for revenue growth, profit margins, and future P/E assumptions. Analyst Commentary Recent research on AdaptHealth shows a mix of cautious adjustments and ongoing confidence, as bullish analysts refine their models in light of the cyberattack and other company specific developments.Aggiornamento narrativa • Jun 22
AHCO: Tuck In Acquisitions And Refinancing Will Shape Future Earnings Profile
AdaptHealth’s latest Narrative Update reflects a modest adjustment to the analyst price target of around $11, as analysts incorporate slightly higher assumed revenue growth, profit margin, and discount rate, along with a marginally lower future P/E multiple in their models. Analyst Commentary on AdaptHealth Recent Street research on AdaptHealth points to a mixed but cautious tone.Aggiornamento narrativa • Jun 06
AHCO: Capitation Contract Execution Will Support Future Cash Flow Repricing
Narrative Update on AdaptHealth Analysts lifted the fair value estimate for AdaptHealth stock from $17 to $18, reflecting recent price target revisions across several firms that cite updated views on the company’s outlook and valuation assumptions. Analyst Commentary Recent Street research on AdaptHealth has centered on a series of price target resets, with several bullish analysts adjusting their models and one taking a more cautious stance.Aggiornamento narrativa • May 22
AHCO: Capitated Contract Investments And Legal Settlement Will Shape Future Earnings Profile
Analysts have nudged their average price target on AdaptHealth higher to about $11.00 from $9.50, reflecting updated views on valuation inputs such as a higher assumed future P/E multiple and recent mixed target changes across firms raising and lowering their dollar-based estimates. Analyst Commentary Recent Street research on AdaptHealth reflects a mix of optimism and caution, with some firms lifting price targets and others trimming them as they reassess assumptions around earnings quality, execution and balance sheet risk.Aggiornamento narrativa • Apr 25
AHCO: Capitated Contract Ramp And Legal Settlement Will Pressure Future Earnings
Analysts have nudged their price targets for AdaptHealth higher by about $1 to $1.50, citing updated views on discount rates, revenue growth, profit margins, and future P/E assumptions reflected in the latest model tweaks. Analyst Commentary Recent research updates show a mixed but generally cautious tone around AdaptHealth, even as some targets move higher at the margin.Aggiornamento narrativa • Apr 10
AHCO: Capitation Contract Execution Will Drive Future Cash Flow Upside
Narrative Update on AdaptHealth Analysts have trimmed their price targets on AdaptHealth, with recent moves including cuts to $9.50 and $14. This reflects mixed views as they weigh operational progress, new capitation business, and recent EBITDA shortfalls and legal costs.Aggiornamento narrativa • Mar 27
AHCO: Forward Contract Ramp And Legal Settlement Will Pressure Profitability
Analysts have trimmed AdaptHealth's consensus price target by $1 to $9.50, reflecting updated views on fair value, discount rates, and profitability after recent operational and legal developments. Analyst Commentary Bearish analysts have recently reset expectations on AdaptHealth, trimming price targets and calling out execution risks tied to both operations and legal events.Aggiornamento narrativa • Mar 13
AHCO: Capitation Ramp And Cash Generation Will Drive Future Upside Potential
Analysts have trimmed their price targets on AdaptHealth, with recent cuts such as $10.50 to $9.50 and $15 to $14. These changes reflect updated views on the impact of increased upfront investment in a major capitated contract and a debt collection settlement on near term earnings.Aggiornamento narrativa • Feb 27
AHCO: Capitation Ramp And Aging At Home Focus Will Support Upside
Narrative Update on AdaptHealth Analysts have trimmed their price targets on AdaptHealth, with recent cuts such as $10.50 to $9.50 and $15 to $14. These changes reflect updated views on the company after operational progress in 2025 was offset by the timing of investments to ramp a large capitated contract and a debt collection legal settlement in North Carolina that affected adjusted EBITDA versus guidance and estimates.Aggiornamento narrativa • Feb 13
AHCO: Connected Health Initiative Will Support Aging At Home Upside
Analysts have kept their $17.00 price target for AdaptHealth unchanged, citing slightly adjusted assumptions around the discount rate, revenue growth, profit margins, and future P/E as the main reasons for maintaining their view. What's in the News AdaptHealth is participating in a new Digital Medicine Society initiative focused on using connected health technology to support independent living for older adults at home.Aggiornamento narrativa • Jan 30
AHCO: Digital Home Health Initiative Will Support Aging At Home Upside
Analysts are holding their fair value estimate for AdaptHealth at US$17.00 per share, citing only modest tweaks to assumptions around discount rate, revenue growth, profit margin and future P/E that do not materially change their overall view. What's in the News AdaptHealth is participating in a Digital Medicine Society initiative focused on technology driven support for older adults living independently, working alongside partners including Validic, Epic Systems, Verizon and Withings to expand connected care and remote monitoring capabilities (Key Developments).Aggiornamento narrativa • Jan 16
AHCO: Digital Home Health Initiative Will Support Aging At Home Opportunity
Analysts have lifted their price target on AdaptHealth from US$16.00 to US$17.00 as they factor in updated assumptions around discount rates, revenue growth, profit margins, and future P/E expectations. What's in the News AdaptHealth is participating in a Digital Medicine Society initiative focused on technology driven support for independent living among older adults, working alongside partners such as Validic, Epic Systems, Verizon, and Withings within the Connected Health Collaborative.Articolo di analisi • Jan 03
AdaptHealth (NASDAQ:AHCO) Takes On Some Risk With Its Use Of Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Articolo di analisi • Oct 18
Here's What's Concerning About AdaptHealth's (NASDAQ:AHCO) Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...Articolo di analisi • Aug 08
AdaptHealth Corp. Just Missed EPS By 31%: Here's What Analysts Think Will Happen Next
NasdaqCM:AHCO 1 Year Share Price vs Fair Value Explore AdaptHealth's Fair Values from the Community and select yours...Articolo di analisi • Jul 23
Insufficient Growth At AdaptHealth Corp. (NASDAQ:AHCO) Hampers Share Price
AdaptHealth Corp.'s ( NASDAQ:AHCO ) price-to-sales (or "P/S") ratio of 0.4x might make it look like a buy right now...Articolo di analisi • Jun 26
Is It Time To Consider Buying AdaptHealth Corp. (NASDAQ:AHCO)?
AdaptHealth Corp. ( NASDAQ:AHCO ), might not be a large cap stock, but it led the NASDAQCM gainers with a relatively...Seeking Alpha • Jun 02
AdaptHealth At A Crossroads: Automation, Integration, And The Future Of Home Care
Summary AdaptHealth's national scale and AI-driven efficiencies position it well for value-based contracts, aiming to curb hospital readmissions and improve EBITDA margins. The company faces potential risks from competitive-bidding discounts, unresolved litigation, and execution challenges on the One Adapt ERP migration. Management's 2025 guidance suggests flat organic revenue and a 21% EBITDA margin, with shares appearing undervalued compared to peers. Long-term investors may find value in accumulating shares below 7× forward EBITDA, while monitoring integration milestones and CMS policy developments. Read the full article on Seeking Alpha
Nuova narrativa • May 15
Adapt Operating System And Debt Reduction Will Transform Home Healthcare
AdaptHealth's focus on geographic expansion, managed care, and partnerships aims to boost market share and drive revenue growth in the home health industry.Articolo di analisi • May 14
We Think AdaptHealth's (NASDAQ:AHCO) Solid Earnings Are Understated
AdaptHealth Corp.'s ( NASDAQ:AHCO ) recent earnings report didn't offer any surprises, with the shares unchanged over...Articolo di analisi • May 09
AdaptHealth Corp. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
AdaptHealth Corp. ( NASDAQ:AHCO ) last week reported its latest quarterly results, which makes it a good time for...Articolo di analisi • Apr 07
Little Excitement Around AdaptHealth Corp.'s (NASDAQ:AHCO) Revenues
AdaptHealth Corp.'s ( NASDAQ:AHCO ) price-to-sales (or "P/S") ratio of 0.4x may look like a pretty appealing investment...Articolo di analisi • Mar 20
At US$10.02, Is It Time To Put AdaptHealth Corp. (NASDAQ:AHCO) On Your Watch List?
AdaptHealth Corp. ( NASDAQ:AHCO ), might not be a large cap stock, but it saw a decent share price growth of 19% on the...Articolo di analisi • Feb 26
These 4 Measures Indicate That AdaptHealth (NASDAQ:AHCO) Is Using Debt Extensively
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Articolo di analisi • Jan 30
Be Wary Of AdaptHealth (NASDAQ:AHCO) And Its Returns On Capital
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Articolo di analisi • Dec 10
AdaptHealth Corp.'s (NASDAQ:AHCO) Revenues Are Not Doing Enough For Some Investors
When close to half the companies operating in the Healthcare industry in the United States have price-to-sales ratios...Articolo di analisi • Nov 13
We Think AdaptHealth (NASDAQ:AHCO) Is Taking Some Risk With Its Debt
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Articolo di analisi • Oct 22
Returns On Capital Signal Tricky Times Ahead For AdaptHealth (NASDAQ:AHCO)
There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...Articolo di analisi • Sep 06
AdaptHealth Corp.'s (NASDAQ:AHCO) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
AdaptHealth Corp. ( NASDAQ:AHCO ) shareholders would be excited to see that the share price has had a great month...Articolo di analisi • Jul 14
Is There An Opportunity With AdaptHealth Corp.'s (NASDAQ:AHCO) 37% Undervaluation?
Key Insights Using the 2 Stage Free Cash Flow to Equity, AdaptHealth fair value estimate is US$16.89 Current share...Articolo di analisi • Jun 25
AdaptHealth Corp.'s (NASDAQ:AHCO) Low P/S No Reason For Excitement
When close to half the companies operating in the Healthcare industry in the United States have price-to-sales ratios...Articolo di analisi • Jun 04
AdaptHealth (NASDAQ:AHCO) Is Reinvesting At Lower Rates Of Return
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Rendimenti per gli azionisti
| AHCO | US Healthcare | US Mercato | |
|---|---|---|---|
| 7D | -47.3% | -0.3% | 4.0% |
| 1Y | -38.1% | 40.5% | 20.7% |
Ritorno vs Industria: AHCO ha avuto una performance inferiore rispetto al US Healthcare che ha registrato un rendimento 40.5 % nell'ultimo anno.
Rendimento vs Mercato: AHCO ha avuto una performance inferiore al mercato US che ha registrato un rendimento 20.7 % nell'ultimo anno.
Volatilità dei prezzi
| AHCO volatility | |
|---|---|
| AHCO Average Weekly Movement | 11.9% |
| Healthcare Industry Average Movement | 7.3% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Prezzo delle azioni stabile: Negli ultimi 3 mesi il prezzo delle azioni di AHCO è stato volatile rispetto al mercato US.
Volatilità nel tempo: La volatilità settimanale ( 12% ) di AHCO è rimasta stabile nell'ultimo anno, ma è comunque superiore al 75% delle azioni US.
Informazioni sull'azienda
| Fondato | I dipendenti | AMMINISTRATORE DELEGATO | Sito web |
|---|---|---|---|
| 2012 | 10,900 | Suzanne Foster | adapthealth.com |
AdaptHealth Corp., insieme alle sue consociate, distribuisce apparecchiature mediche a domicilio (HME), forniture mediche e servizi a domicilio e correlati negli Stati Uniti. Opera attraverso i segmenti Sleep Health, Respiratory Health, Diabetes Health e Wellness at Home. L'azienda offre apparecchiature per la terapia del sonno, forniture e servizi correlati, come la pressione positiva continua delle vie aeree e i servizi BiLevel per le persone che soffrono di apnea ostruttiva del sonno; apparecchiature e forniture per l'ossigeno e la ventilazione meccanica domiciliare e servizi correlati per la terapia cronica; dispositivi medici, tra cui i monitor per il glucosio continuo e le pompe per l'insulina per il trattamento del diabete; HME per i pazienti dimessi da strutture per acuti e altre strutture; altri dispositivi e forniture HME.
AdaptHealth Corp. Riepilogo dei fondamenti
| AHCO statistiche fondamentali | |
|---|---|
| Capitalizzazione di mercato | US$759.10m |
| Utili (TTM) | -US$231.09m |
| Ricavi(TTM) | US$3.36b |
0.2x
Rapporto P/S-3.3x
Rapporto P/EAHCO è sopravvalutato?
Vedi Fair Value e analisi di valutazioneUtili e ricavi
| AHCO Conto economico (TTM) | |
|---|---|
| Ricavi | US$3.36b |
| Costo del fatturato | US$2.72b |
| Profitto lordo | US$644.93m |
| Altre spese | US$876.03m |
| Utili | -US$231.09m |
Ultimi utili riportati
Jun 30, 2026
Prossima data di guadagno
n/a
| Utile per azione (EPS) | -1.73 |
| Margine lordo | 19.18% |
| Margine di profitto netto | -6.87% |
| Rapporto debito/patrimonio netto | 136.2% |
Come si è comportato AHCO nel lungo periodo?
Vedi performance storica e confrontoAnalisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/08/07 21:19 |
| Prezzo dell'azione a fine giornata | 2026/08/07 00:00 |
| Utili | 2026/06/30 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
AdaptHealth Corp. è coperta da 11 analisti. 6 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Eric Coldwell | Baird |
| Kevin Fischbeck | BofA Global Research |
| Joanna Sylvia Gajuk | BofA Global Research |